HBOT Regulation Guide: FDA, UHMS, and Clinic Accreditation

Last updated: April 2026

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before starting any treatment.

Affiliate Disclosure: We may earn a commission when you purchase through our links. This does not affect our editorial independence.

Quick Answer

The Undersea & Hyperbaric Medical Society (UHMS) lists 14 primary indications for hyperbaric oxygen therapy in its 14th edition, covering conditions like carbon monoxide poisoning and decompression sickness UHMS Hyperbaric Oxygen Therapy Indications (14th Ed.).
The FDA recommends UHMS-accredited facilities for specific illnesses, highlighting the importance of robust oversight and adherence to established medical standards.
Gas embolism, a condition where gas bubbles enter arteries or veins, can be caused by pulmonary barotrauma after an ascent of as little as one meter in diving.
In human studies, a continuous intravenous infusion of oxygen at 10 mL/min was tolerated, but increasing it to 20 mL/min caused symptoms UHMS Hyperbaric Oxygen Therapy Indications (2020).

Hyperbaric oxygen therapy (HBOT) is a medical treatment where patients breathe 100% oxygen in a chamber pressurized to greater than normal atmospheric pressure. This specialized therapy is regulated by various bodies to ensure patient safety and treatment effectiveness. The U.S. Food and Drug Administration (FDA) plays a role in device approval, while the Undersea & Hyperbaric Medical Society (UHMS) sets the clinical standards and guidelines for its use. The UHMS, for instance, publishes a comprehensive list of 14 primary indications for HBOT, which are considered the accepted medical conditions for this treatment. These indications range from acute conditions like air or gas embolism and carbon monoxide poisoning to chronic issues such as problem wounds and delayed radiation injuries. The FDA specifically recommends that patients seek treatment for certain illnesses at UHMS-accredited hyperbaric facilities, underscoring the value of such accreditation in maintaining high standards of care and ensuring that clinics operate within recognized medical protocols. This collaboration between regulatory bodies and professional societies helps to guide both practitioners and patients toward safe and effective HBOT applications. See the arterial gas embolism evidence atlas for the full study-by-study evidence breakdown. See the carbon monoxide poisoning evidence atlas for the full study-by-study evidence breakdown.

What is Hyperbaric Oxygen Therapy (HBOT)?

Hyperbaric oxygen therapy (HBOT) is a medical procedure that involves breathing 100% oxygen within a specially designed chamber where the atmospheric pressure is significantly increased. This definition is formally recognized and guided by organizations like the Undersea & Hyperbaric Medical Society (UHMS), which provides extensive guidelines and reports on the proper application and understanding of HBOT. The core principle behind HBOT is to deliver a much higher concentration of oxygen to the body's tissues than what is possible under normal atmospheric conditions. By increasing the pressure, more oxygen dissolves into the blood plasma, allowing it to reach areas of the body that might be deprived of oxygen due to injury or illness. This enhanced oxygen delivery can promote healing, reduce swelling, and fight certain types of infections.

The Science Behind Increased Pressure

When a patient enters a hyperbaric chamber, the pressure inside is gradually increased. This pressure is typically measured in atmospheres absolute (ATA), with normal atmospheric pressure at sea level being 1 ATA. During HBOT, the pressure is elevated to levels like 2 or 3 ATA, which means the air pressure inside the chamber is two or three times greater than outside. This increased pressure forces oxygen into the body's fluids, including the plasma, cerebrospinal fluid, and lymph. Normally, red blood cells carry most of the oxygen, but under hyperbaric conditions, the dissolved oxygen in plasma becomes a significant contributor to tissue oxygenation. This mechanism is particularly beneficial in conditions where blood flow is compromised or when tissues are struggling to heal due to lack of oxygen.

Types of Hyperbaric Chambers

There are different types of hyperbaric chambers used for HBOT. These generally fall into two categories: monoplace and multiplace chambers. Monoplace chambers are designed for a single patient, who lies down inside a transparent acrylic cylinder and breathes 100% oxygen directly. The entire chamber is pressurized with 100% oxygen. Multiplace chambers, on the other hand, can accommodate several patients at once, along with medical staff. In multiplace chambers, the room is pressurized with compressed air, and patients breathe 100% oxygen through masks or hoods. Both types of chambers achieve the same therapeutic effect of delivering high-concentration oxygen under pressure, but they differ in their operational setup and the number of patients they can treat simultaneously. The choice of chamber often depends on the specific medical facility, the patient's condition, and the overall treatment protocol. Regardless of the chamber type, the goal remains the same: to provide therapeutic doses of oxygen to promote healing and mitigate disease processes. The use of these chambers must always adhere to strict safety protocols and medical guidelines to ensure patient well-being.

UHMS Role in Defining HBOT

The Undersea & Hyperbaric Medical Society plays a critical role in defining and standardizing hyperbaric oxygen therapy. Their publications, such as the "Hyperbaric Oxygen Therapy Indications" 14th Edition, serve as authoritative references for the medical community UHMS Hyperbaric Oxygen Therapy Indications (14th Ed.). This document provides a clear definition of HBOT, outlines its accepted medical indications, and details the protocols for its safe and effective use. The UHMS definition emphasizes the administration of 100% oxygen at pressures greater than normal atmospheric pressure, which is crucial for achieving therapeutic effects. Beyond just defining the therapy, the UHMS also sets standards for utilization review, ensuring that HBOT is used appropriately and only for conditions where its efficacy has been scientifically established. They also have a process for accepting new indications, which involves rigorous review of scientific evidence. This structured approach ensures that HBOT remains a credible and evidence-based medical treatment, distinguishing it from unproven or experimental applications. The society's dedication to research and education helps to advance the understanding of hyperbaric medicine and its benefits for patients suffering from a range of complex medical conditions.

What are the FDA-Recognized HBOT Indications?

The U.S. Food and Drug Administration (FDA) recognizes the importance of proper oversight in hyperbaric oxygen therapy (HBOT) and specifically recommends that patients seek treatment for certain illnesses at facilities accredited by the Undersea & Hyperbaric Medical Society (UHMS). This recommendation underscores the FDA's reliance on the UHMS as the leading authority for defining medically accepted HBOT indications. The UHMS, in its various editions of "Hyperbaric Oxygen Therapy Indications," lists 14 primary conditions for which HBOT is considered an effective and appropriate treatment. These conditions cover a wide spectrum of medical issues, from acute emergencies to chronic non-healing wounds.

The UHMS 14th Edition Indications

The UHMS 14th Edition of "Hyperbaric Oxygen Therapy Indications" outlines a comprehensive list of 14 primary conditions that are recognized for HBOT treatment. This edition serves as the most current reference for medical professionals and clinics offering hyperbaric services. The listed indications include:

Air or Gas Embolism
Arterial Insufficiencies (including Central Retinal Artery Occlusion and Selected Problem Wounds)
Carbon Monoxide Poisoning
Clostridial Myonecrosis (Gas Gangrene)
Compromised Grafts and Flaps
Acute Traumatic Ischemias
Decompression Sickness
Delayed Radiation Injuries (Soft Tissue and Bony Necrosis)
Sudden Sensorineural Hearing Loss
Intracranial Abscess
Necrotizing Soft Tissue Infections
Refractory Osteomyelitis
Severe Anemia
Adjunctive Hyperbaric Oxygen Therapy in the Treatment of Thermal Burns

Each of these indications is backed by extensive research and clinical evidence, as detailed within the UHMS report. For example, the treatment of air or gas embolism is described as a critical application, especially in cases arising from diving accidents or medical procedures. The UHMS provides detailed chapters on each indication, offering guidance on diagnosis, treatment protocols, and expected outcomes. The document also includes a preface, background information, and definitions of hyperbaric oxygen, ensuring a thorough understanding for practitioners. The UHMS 14th Edition lists 14 primary indications for HBOT, making it a crucial resource for anyone involved in hyperbaric medicine UHMS Hyperbaric Oxygen Therapy Indications (14th Ed.).

Consistency Across Editions: 13th and 14th Editions

It is important to note the consistency in the recognized indications across different editions of the UHMS guidelines. The UHMS 13th Edition of "Hyperbaric Oxygen Therapy Indications" also lists 14 primary indications, demonstrating a stable and well-established set of conditions for which HBOT is deemed effective UHMS Hyperbaric Oxygen Therapy Indications (13th Ed.). While the specific numbering or sub-categorization might see minor adjustments between editions, the core conditions remain consistently recognized. For instance, both editions feature sections on arterial insufficiencies, which encompass conditions like central retinal artery occlusion and the enhancement of healing in selected problem wounds. This continuity assures patients and providers that the therapeutic applications of HBOT are based on a long-standing body of evidence and expert consensus. The UHMS committee, comprised of leading experts, meticulously reviews and updates these guidelines, ensuring they reflect the latest scientific understanding and best clinical practices in hyperbaric medicine. The rigorous process for accepting new indications, as described by the UHMS, involves careful evaluation of research, further solidifying the evidence-based nature of these recognized treatments.

Why FDA Recommends UHMS Accreditation

The FDA's recommendation for UHMS-accredited facilities is a strong endorsement of the quality and safety standards upheld by the UHMS. This recommendation helps patients identify reputable clinics that adhere to established medical guidelines and protocols. It acts as a safeguard, guiding individuals away from facilities that might offer HBOT for unproven or "off-label" conditions, which could potentially expose patients to unnecessary risks or ineffective treatments. By aligning with UHMS accreditation, the FDA emphasizes that while HBOT devices themselves are regulated, the clinical application of the therapy requires specialized expertise and adherence to specific medical indications. This partnership between a federal regulatory body and a professional medical society provides a clear framework for responsible and effective hyperbaric oxygen therapy, ensuring that patients receive care that is both safe and evidence-based.

How Does UHMS Accreditation Ensure Quality and Safety?

UHMS accreditation is a critical benchmark that ensures a hyperbaric facility meets rigorous standards for patient care, operational safety, and clinical efficacy. When a facility achieves UHMS accreditation, it signifies that it has undergone a thorough review process and demonstrated adherence to the highest professional and safety guidelines in hyperbaric medicine. This process covers various aspects of clinic operation, from the qualifications of medical staff to the maintenance of equipment and the development of appropriate treatment protocols. The FDA's recommendation for UHMS-accredited facilities for treating specific illnesses further reinforces the importance of this oversight, providing patients with a clear indicator of a reliable and safe treatment environment.

The Rigorous Accreditation Process

The process of UHMS accreditation is comprehensive and demanding. It involves an in-depth evaluation of a hyperbaric facility's policies, procedures, equipment, and personnel. Experts from the UHMS conduct on-site visits to assess compliance with established standards. This includes examining the credentials of physicians, nurses, and hyperbaric technicians to ensure they possess the necessary training and experience to administer HBOT safely and effectively. The accreditation team also reviews patient safety protocols, emergency preparedness plans, and quality assurance programs. For example, they verify that chambers are properly maintained and operated according to manufacturer specifications and industry best practices. The goal is to ensure that every aspect of the facility's operation contributes to a safe and therapeutic environment for patients. Clinics seeking accreditation can also participate in workshops designed to help them prepare for the rigorous review process, highlighting the UHMS's commitment to supporting quality improvement across the field.

Benefits for Patients and Providers

For patients, choosing a UHMS-accredited facility offers significant peace of mind. It means they are receiving care in an environment that has been independently verified to meet high standards of safety and medical practice. This helps to protect patients from potential risks associated with improperly administered HBOT or treatment for unproven conditions. The FDA's explicit recommendation for UHMS-accredited facilities for specific illnesses directly guides patients toward safe and effective care FDA Recommendation for UHMS-Accredited Facilities. For providers, UHMS accreditation demonstrates a commitment to excellence and provides a competitive advantage. It assures referring physicians that their patients will receive high-quality, evidence-based care. Accreditation also fosters a culture of continuous improvement within the facility, as staff are encouraged to stay updated on the latest research and best practices in hyperbaric medicine. This commitment to ongoing education and adherence to guidelines ultimately benefits everyone involved in the hyperbaric treatment process.

Adherence to Established Medical Guidelines

A cornerstone of UHMS accreditation is the strict adherence to established medical guidelines, particularly regarding the indications for HBOT. The UHMS publishes its "Hyperbaric Oxygen Therapy Indications" to provide clear, evidence-based guidance on when HBOT is medically appropriate. These guidelines are developed by a committee of experts and are updated regularly to reflect new research and clinical understanding. By requiring facilities to treat only UHMS-approved indications, accreditation helps to prevent the misuse of HBOT for conditions where its efficacy has not been scientifically proven. This focus on evidence-based practice is crucial for maintaining the credibility and integrity of hyperbaric medicine. It ensures that patients are not subjected to expensive or potentially risky treatments that lack scientific validation. The UHMS also provides resources for continuing education, including online portals and introductory 40-hour training courses, further supporting the professional development of hyperbaric practitioners and reinforcing the importance of adhering to these critical guidelines.

What is Air or Gas Embolism and How Does HBOT Treat It?

Air or gas embolism is a serious medical condition that occurs when gas bubbles enter the arteries or veins, obstructing blood flow and potentially causing significant tissue damage or organ failure. This can manifest as either arterial gas embolism (AGE), where bubbles are in the arteries, or venous gas embolism (VGE), where they are in the veins. Hyperbaric oxygen therapy (HBOT) is a primary treatment for gas embolism because it works to reduce the size of these gas bubbles and improve oxygen delivery to affected tissues. The high pressure in a hyperbaric chamber physically compresses the gas bubbles, making them smaller and less obstructive. Simultaneously, the 100% oxygen helps to wash out inert gases like nitrogen from the bubbles, further shrinking them and allowing the body to reabsorb them more efficiently.

Causes of Gas Embolism

Gas embolism can arise from a variety of sources, both diving-related and non-diving related. Richard E. Moon, in "Hyperbaric Oxygen Therapy Indications: Air or Gas Embolism," explains that arterial gas embolism was originally described during submarine escape training, where pulmonary barotrauma occurred during free ascent after breathing compressed gas at depth. He states, "Pulmonary barotrauma and gas embolism due to breath holding can occur after an ascent of as little as one meter." This highlights the extreme sensitivity of the lungs to pressure changes. Beyond diving, AGE can also result from blast injuries, mechanical ventilation, penetrating chest trauma, or even medical procedures like chest tube placement and bronchoscopy.

Venous gas embolism (VGE) is common after compressed gas diving, but normally, these bubbles are trapped by the pulmonary capillaries and do not cause symptoms. However, large volumes of VGE can overwhelm the lungs, leading to cough, dyspnea, and pulmonary edema. If the pulmonary capillary network is overwhelmed, or if a patient has a patent foramen ovale or atrial septal defect, VGE bubbles can cross into the arterial circulation, becoming AGE. Causes of gas embolism unrelated to diving are numerous and include accidental intravenous air injection, cardiopulmonary bypass accidents, needle biopsy of the lung, hemodialysis, and central venous catheter placement or disconnection. Gastrointestinal endoscopy, hydrogen peroxide irrigation or ingestion, arthroscopy, cardiopulmonary resuscitation, and percutaneous hepatic puncture are also listed causes. Even non-medical activities such as blowing air into the vagina during orogenital sex or sexual intercourse after childbirth can lead to air embolism. Surgical procedures where the site is under pressure, like laparoscopy, transurethral surgery, vitrectomy, endoscopic vein harvesting, and hysteroscopy, can also cause air embolism. Massive VGE can occur due to passive entry of air into surgical wounds that are elevated above the level of the heart, where pressure in adjacent veins is subatmospheric. This has been noted in sitting craniotomy, cesarean section, various prostatectomy approaches, spine surgery, hip replacement, liver resection, liver transplantation, and dental implant insertion UHMS Hyperbaric Oxygen Therapy Indications (2020).

How HBOT Works for Embolism

HBOT addresses gas embolism through two primary mechanisms: gas compression and gas washout. When a patient with a gas embolism is placed in a hyperbaric chamber, the increased ambient pressure physically compresses the gas bubbles in the bloodstream. According to Boyle's Law, as pressure increases, the volume of a gas decreases. This reduction in bubble size allows blood to flow past the obstruction more easily, restoring circulation to deprived tissues. For instance, if a bubble is blocking a small artery, compressing it can allow blood to flow around or through the now smaller obstruction, delivering vital oxygen.

The second mechanism, gas washout, involves the high partial pressure of oxygen (PO2) in the blood. By breathing 100% oxygen under pressure, the patient's blood becomes super-saturated with oxygen. This high oxygen level creates a steep gradient between the oxygen in the blood and the inert gas (primarily nitrogen) within the embolism bubbles. This gradient promotes the diffusion of the inert gas out of the bubbles and into the blood, where it can be safely exhaled by the lungs. This process effectively "washes out" the problematic gas from the bubbles, further reducing their size and accelerating their reabsorption by the body. Richard E. Moon notes that "Clinical deficits can occur after intra-arterial injection of only small volumes of air. Intravenous injection is often asymptomatic." He also states that "Injection of up to 0.5-1 mL/kg has been tolerated in experimental animals." In humans, "continuous IV infusion of oxygen at 10 mL/min has been reported as well tolerated, while 20 mL/min caused symptoms," indicating a threshold for tolerance. Compared to constant infusions, air injections are more likely to cause clinical abnormalities. This highlights the dangers of even small volumes of air in the wrong place, and why HBOT is crucial for treatment.

Criticality of Prompt Treatment

Prompt treatment with HBOT is crucial for gas embolism, especially for arterial gas embolism, which can lead to severe neurological deficits, cardiac arrest, or death if not addressed quickly. The rapid reduction in bubble size and improved oxygenation offered by HBOT can significantly reduce morbidity and mortality. Delayed treatment can result in permanent tissue damage, particularly in the brain and heart, due to prolonged oxygen deprivation. Therefore, gas embolism is considered a hyperbaric emergency, requiring immediate transfer to a facility capable of delivering HBOT. The efficacy of HBOT in treating gas embolism is a well-established indication, consistently listed in UHMS guidelines, underscoring its vital role in emergency medicine and diving accident management.

Beyond Embolism: Other Key HBOT Indications

While air or gas embolism is a critical and well-known indication for hyperbaric oxygen therapy (HBOT), the Undersea & Hyperbaric Medical Society (UHMS) recognizes a broad range of other conditions that benefit from this specialized treatment. The UHMS has meticulously compiled a list of 14 primary indications, which are detailed in their authoritative "Hyperbaric Oxygen Therapy Indications" reports. These additional indications demonstrate the diverse therapeutic applications of HBOT, extending its utility across various medical specialties from wound care to infectious diseases and radiation injury management. Each condition on this list has undergone rigorous scientific review to ensure that HBOT provides a proven benefit.

Addressing Arterial Insufficiencies and Problem Wounds

One significant area where HBOT offers substantial benefit is in the treatment of arterial insufficiencies and selected problem wounds. This category includes conditions like central retinal artery occlusion, which is an acute blockage of blood flow to the retina, potentially leading to sudden vision loss. HBOT can help by increasing oxygen delivery to the ischemic retina, potentially salvaging vision. Furthermore, HBOT is indicated for the enhancement of healing in selected problem wounds, particularly those that are chronic, non-healing, or complicated by poor circulation, infection, or diabetes. These might include diabetic foot ulcers, pressure ulcers, or venous stasis ulcers that have failed to respond to conventional treatments. The increased oxygen levels delivered during HBOT promote angiogenesis (formation of new blood vessels), stimulate fibroblast activity, enhance collagen production, and improve the function of white blood cells, all of which are crucial for wound healing. It helps to overcome the hypoxic (low oxygen) environment often found in chronic wounds, accelerating tissue repair and reducing the risk of amputation.

Treating Infections and Compromised Tissues

HBOT is also a vital adjunctive therapy for several severe infections and conditions involving compromised tissues. Clostridial myonecrosis, commonly known as gas gangrene, is a rapidly progressing bacterial infection that produces toxins and gas in soft tissues. HBOT is effective here because the high oxygen environment is toxic to the anaerobic bacteria (Clostridium species) that cause the infection and helps to reduce the production and spread of their toxins. Similarly, necrotizing soft tissue infections, which are severe bacterial infections that cause tissue death, also benefit from HBOT by improving oxygenation to infected areas, enhancing the body's immune response, and directly inhibiting bacterial growth. Compromised grafts and flaps, often seen after reconstructive surgery, are another key indication. When these tissues lack adequate blood supply and oxygen, HBOT can improve their viability by promoting neovascularization and reducing ischemia, thereby preventing tissue loss and improving surgical outcomes.

Managing Traumatic Injuries and Radiation Damage

Acute traumatic ischemias, which involve severe reduction or cessation of blood flow to tissues following injury, are also treated with HBOT. This can include crush injuries or compartment syndrome, where tissues are starved of oxygen. HBOT helps to reduce edema, preserve tissue viability, and promote healing in these time-sensitive situations. Decompression sickness, a condition affecting divers when dissolved gases come out of solution and form bubbles in the body upon ascent, is another primary indication. HBOT is the definitive treatment, as it recompresses the bubbles and facilitates their washout, similar to its mechanism in gas embolism. Delayed radiation injuries, which can manifest as soft tissue or bony necrosis (osteoradionecrosis) months or years after radiation therapy, are also responsive to HBOT. The therapy helps to repair damaged tissues by improving blood supply, stimulating cell growth, and reducing inflammation in radiation-damaged areas, significantly improving quality of life for affected patients.

Other Specialized Applications

Beyond these, the UHMS lists several other specialized applications for HBOT. Sudden sensorineural hearing loss (SSNHL), an unexplained rapid loss of hearing, can be treated with HBOT, especially if initiated promptly, as it may improve oxygen delivery to the inner ear. Intracranial abscess, a collection of pus within the brain, can also be managed with adjunctive HBOT, which enhances the effectiveness of antibiotics by improving oxygenation in the infected area, an environment often hostile to antibiotic penetration. Refractory osteomyelitis, a persistent bone infection that does not respond to conventional treatments, benefits from HBOT by improving oxygen delivery to the infected bone, enhancing immune function, and promoting bone healing. Severe anemia, when blood transfusions are not possible or are contraindicated, can be an indication for HBOT, as the dissolved oxygen in plasma can temporarily sustain life by compensating for the reduced oxygen-carrying capacity of red blood cells. Finally, HBOT serves as an adjunctive therapy in the treatment of thermal burns, helping to reduce edema, promote wound healing, and decrease the risk of infection in severely burned patients. These diverse indications highlight the broad therapeutic potential of HBOT when applied according to established medical guidelines.

Who are the Experts Behind HBOT Guidelines?

The development and ongoing refinement of hyperbaric oxygen therapy (HBOT) guidelines are the responsibility of a dedicated group of professionals, primarily through the Hyperbaric Oxygen Therapy Committee of the Undersea & Hyperbaric Medical Society (UHMS). This committee comprises leading experts in hyperbaric and diving medicine, who possess extensive clinical experience, research knowledge, and a deep understanding of the physiological effects of hyperbaric environments. Their collective expertise is crucial for ensuring that the guidelines are evidence-based, clinically relevant, and adhere to the highest standards of medical practice. These individuals are the driving force behind the comprehensive reports and recommendations that guide HBOT practitioners worldwide.

The Hyperbaric Oxygen Therapy Committee

The Hyperbaric Oxygen Therapy Committee is a standing body within the UHMS, tasked with continuously reviewing and updating the accepted indications for HBOT. This committee is composed of physicians and scientists specializing in hyperbaric medicine, critical care, diving medicine, wound care, and other relevant fields. Their work involves a rigorous process of evaluating scientific literature, clinical trials, and expert consensus to determine the efficacy and safety of HBOT for various conditions. They are responsible for authoring and revising the "Hyperbaric Oxygen Therapy Indications" reports, which are considered the definitive guides in the field. For example, Dr. Lindell K. Weaver MD served as the Chair and Editor for the Thirteenth Edition of the "Hyperbaric Oxygen Therapy Indications." This leadership role involves coordinating the contributions of numerous committee members and ensuring the accuracy and clarity of the published guidelines. The committee members contribute to the detailed reports found in publications like the 13th and 14th Editions of the 'Hyperbaric Oxygen Therapy Indications', ensuring a robust scientific foundation for the field.

Dedication to Evidence-Based Practice

The UHMS and its committee are deeply committed to evidence-based practice. This means that every indication for HBOT listed in their reports is supported by substantial scientific evidence, typically from peer-reviewed research and clinical studies. The committee's process for accepting new indications is particularly stringent, requiring a thorough review of available data to ensure that any new application of HBOT is both safe and effective. This commitment helps to differentiate medically legitimate uses of HBOT from unproven or experimental applications that may lack scientific backing. The UHMS explicitly states in its 13th Edition that "No responsibility is assumed by the Publisher or Editor for any injury and or damage to persons or property as a matter of product liability, negligence or otherwise, or from any use or operation of any methods, product, instructions, or ideas contained in the material herein. No suggested test or procedure should be carried out unless, in the reader’s judgment, its risk is justified. Because of rapid advances in the medical sciences, we recommend that the independent verification of diagnoses and drug dosages be made," as stated by Lindell K. Weaver MD, Chair and Editor, Undersea and Hyperbaric Medical Society (13th Edition). This statement underscores the critical need for continuous verification and professional judgment in applying medical treatments, including HBOT.

Guiding the Medical Community

The guidelines produced by the UHMS Hyperbaric Oxygen Therapy Committee serve as an indispensable resource for the entire medical community. They provide essential information for physicians, nurses, and hyperbaric technicians on how to safely and effectively administer HBOT. These reports also inform insurance companies about which conditions are medically justified for coverage, and they guide regulatory bodies like the FDA in their recommendations for patient care. By providing clear, authoritative, and regularly updated guidelines, the UHMS helps to ensure that HBOT is used responsibly and to the greatest benefit of patients. The society's dedication to education, through resources like online continuing education portals and introductory training courses, further supports the widespread adoption of these expert-driven guidelines, ensuring that practitioners are well-informed and competent in delivering hyperbaric oxygen therapy.

Frequently Asked Questions

What is the main purpose of UHMS accreditation for HBOT clinics?

The main purpose of UHMS accreditation for HBOT clinics is to ensure that facilities meet rigorous standards for patient care, safety, and clinical efficacy. This accreditation signifies that a clinic adheres to the highest professional guidelines in hyperbaric medicine, covering aspects from staff qualifications to equipment maintenance and treatment protocols. The FDA specifically recommends UHMS-accredited facilities for treating certain illnesses, highlighting the importance of this oversight in guiding patients toward safe and reliable treatment options FDA Recommendation for UHMS-Accredited Facilities. It helps to prevent the misuse of HBOT for unproven conditions and promotes evidence-based practice.

How many conditions are officially recognized by the UHMS for HBOT treatment?

The Undersea & Hyperbaric Medical Society (UHMS) officially recognizes 14 primary conditions for HBOT treatment. These indications are detailed in their comprehensive "Hyperbaric Oxygen Therapy Indications" reports, such as the 14th Edition. This list includes conditions like air or gas embolism, carbon monoxide poisoning, decompression sickness, and various types of problem wounds UHMS Hyperbaric Oxygen Therapy Indications (14th Ed.). Each of these indications is backed by extensive scientific research and clinical evidence, ensuring that HBOT is applied effectively and appropriately.

Can hyperbaric oxygen therapy be used for non-medical or 'off-label' purposes?

While HBOT devices themselves are regulated by the FDA, the UHMS guidelines specifically define the medically recognized indications for HBOT. Using HBOT for non-medical or "off-label" purposes, meaning for conditions not on the UHMS list, is generally not supported by the medical community and may not be covered by insurance. The FDA's recommendation for UHMS-accredited facilities is partly to guide patients toward treatments for specific illnesses that have proven efficacy, discouraging the use of HBOT for unproven claims. The UHMS emphasizes evidence-based practice and continuous review of scientific literature for accepting new indications.

What is the difference between arterial gas embolism (AGE) and venous gas embolism (VGE)?

Arterial gas embolism (AGE) occurs when gas bubbles enter the arterial circulation, which carries oxygenated blood away from the heart to the body's tissues. This is often more serious as bubbles can directly obstruct blood flow to vital organs like the brain or heart. Venous gas embolism (VGE) occurs when gas bubbles enter the venous circulation, which carries deoxygenated blood back to the heart. Normally, VGE bubbles are filtered out by the lungs and do not cause symptoms. However, large volumes of VGE can overwhelm the lungs, or if a patient has certain heart defects, these bubbles can cross into the arterial circulation, becoming AGE. Pulmonary barotrauma and gas embolism due to breath holding can occur after an ascent of as little as one meter UHMS Hyperbaric Oxygen Therapy Indications (2020).

Where can I find the most current UHMS guidelines for HBOT indications?

The most current UHMS guidelines for HBOT indications can be found directly on the Undersea & Hyperbaric Medical Society website. Their "Hyperbaric Oxygen Therapy Indications" report, specifically the latest 14th Edition, serves as the authoritative reference. This document provides detailed information on the 14 recognized conditions for which HBOT is indicated, along with background information, definitions, and considerations for utilization review. Accessing these guidelines directly from the UHMS ensures you have the most up-to-date and accurate information from the leading professional society in the field.